1-20 of 22
Marina Ruggeri
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Imaging FDG-PET/CT Minimal Residual Disease Assessment on Outcomes and Matching with Bone Marrow Techniques in Newly Diagnosed Transplant Eligible Multiple Myeloma (MM) Patients: Results of the Phase II Randomized Forte Trial

Elena Zamagni, Cristina Nanni, MD, Francesca Gay, MD, Luca Dozza, MSc, Delia Rota Scalabrini, Mattia D'Agostino, MD, Rossella Ribolla, MD, Monica Galli, Manuela Racca, MD, Renato Zambello, Elena Rivolti, MD, Domenico Albano, MD, Annibale Versari, MD, Mariella Grasso, Rossella Troia, PharmD, Antonio Spadano, Francesca Patriarca, Marina Ruggeri, Marco Rensi, MD, Anna Pascarella, Pietro Zucchetta, MD, Paola Tacchetti, Stefano Fanti, MD PhD, Mario Boccadoro, Michele Cavo, Pellegrino Musto, Stefania Oliva
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-137412
Published: 2020
Journal Articles

Impact of Minimal Residual Disease (MRD) By Multiparameter Flow Cytometry (MFC) and Next-Generation Sequencing (NGS) on Outcome: Results of Newly Diagnosed Transplant-Eligible Multiple Myeloma (MM) Patients Enrolled in the Forte Trial

Stefania Oliva, Elisa Genuardi, Maria Teresa Petrucci, Mattia D'Agostino, MD, Daniel Auclair, Antonio Spadano, Allison P. Jacob, Michele Cea, Luca De Rosa, Alessandro Gozzetti, Marina Ruggeri, Andrea Capra, Milena Gilestro, Norbert Pescosta, Angelo D. Palmas, Agostina Siniscalchi, Ilan R. Kirsch, Paolo Corradini, Pellegrino Musto, Mario Boccadoro, Elena Zamagni, Francesca Gay, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 44–45.
https://doi.org/10.1182/blood-2020-137351
Published: 2020
Journal Articles

Impact of Gain and Amplification of 1q in Newly Diagnosed Multiple Myeloma Patients Receiving Carfilzomib-Based Treatment in the Forte Trial

Mattia D'Agostino, MD, Marina Ruggeri, Sara Aquino, Nicola Giuliani, Maddalena Arigoni, Massimo Gentile, Martina Olivero, Iolanda Donatella Vincelli, Andrea Capra, Chiara Mussatto, Antonio Ledda, Paola Tacchetti, Caterina Musolino, Claudia Cellini, Francesca Patriarca, Stelvio Ballanti, Raffaele Calogero, Pellegrino Musto, Mario Boccadoro, Francesca Gay, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 38–40.
https://doi.org/10.1182/blood-2020-137060
Published: 2020
Journal Articles

MRD Evaluation By PET/CT According to Deauville Criteria Combined with Multiparameter Flow Cytometry in Newly Diagnosed Transplant Eligible Multiple Myeloma (MM) Patients Enrolled in the Phase II Randomized Forte Trial

Elena Zamagni, MD, Cristina Nanni, Francesca Gay, MD, Luca Dozza, MSc, Delia Rota Scalabrini, Paola Omedé, Rossella Ribolla, MD, Monica Galli, Manuela Racca, Renato Zambello, Barbara Gamberi, MD, Domenico Albano, Annibale Versari, Mariella Grasso, Rossella Troia, Tonino Spadano, Francesca Patriarca, Marina Ruggeri, Marco Rensi, Anna Pascarella, Pietro Zucchetta, MD, Paola Tacchetti, Stefano Fanti, Prof, MD PhD, Mario Boccadoro, Michele Cavo, Stefania Oliva
Journal: Blood
Blood (2019) 134 (Supplement_1): 4321.
https://doi.org/10.1182/blood-2019-125134
Published: 2019
Journal Articles

Tumor Circulating Plasma Cells Detected By Flow Cytometric Single Platform Method Correlate with Clinical Response to Therapy and Unfavorable Patients' Characteristics

Vittorio Emanuele Muccio, Milena Gilestro, Elona Saraci, Andrea Capra, Alessandro Costa, Marina Ruggeri, Simona Caltagirone, Daniela Oddolo, Chiara Mussatto, Pellegrino Musto, Lucia Pantani, Vincenzo Pavone, Sonia Ronconi, Iolanda Donatella Vincelli, Anna Maria Cafro, Claudia Cellini, Vanessa Innao, Eugenio Piro, Francesca Gay, MD, Mario Boccadoro, Paola Omedé
Journal: Blood
Blood (2019) 134 (Supplement_1): 4357.
https://doi.org/10.1182/blood-2019-122657
Published: 2019
Journal Articles

Impact of Treatment Intensification According to Patient Prognosis: A Pooled Analysis of 3 Randomized Phase III Trials

Francesca Gay, MD, Mattia D'Agostino, MD, Roman Hajek, prof, MD PhD, Sara Bringhen, MD, Concetta Conticello, MD, Gianluca Gaidano, MD PhD, Vittorio Montefusco, Sara Pezzatti, MD, Marco Salvini, MD, Tommaso Caravita, MD, Anna Maria Cafro, MD, Michele Cavo, MD, Marina Ruggeri, Fortunato Morabito, MD, Roberto Mina, MD, Luca Baldini, MD Prof, Giulia Benevolo, MD, Tommasina Guglielmelli, MD, Annalisa Bernardini, Roberto Foà, MD, Francesca Patriarca, MD, Massimo Offidani, MD, Roberto Ria, MD, Dina Ben Yehuda, MD, Maria Teresa Petrucci, MD, Andrew Spencer, MD, Antonio Palumbo, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2016) 128 (22): 995.
https://doi.org/10.1182/blood.V128.22.995.995
Published: 2016
Journal Articles

HIF-1α Upregulation in TP53 Disrupted Chronic Lymphocytic Leukemia Cells and Its Potential Role As a Therapeutic Target

Valentina Griggio, Ms, Candida Vitale, MD, Maria Todaro, PhD, Chiara Riganti, MD, Joanna Kopecka, PhD, Michele Dal Bo, Davide Rossi, Gabriele Pozzato, MD, Monia Marchetti, MD PhD, Marina Ruggeri, Paola Omedè, PhD, Luca Laurenti, Giovanni Del Poeta, MD, Francesca Romana Mauro, MD PhD, Valter Gattei, Gianluca Gaidano, MD PhD, Robin Foa, Massimo Massaia, MD, Mario Boccadoro, MD, Marta Coscia, MD PhD
Journal: Blood
Blood (2016) 128 (22): 305.
https://doi.org/10.1182/blood.V128.22.305.305
Published: 2016
Journal Articles

Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma

Clinical Trials & Observations
Valeria Magarotto, Sara Bringhen, Massimo Offidani, Giulia Benevolo, Francesca Patriarca, Roberto Mina, Antonietta Pia Falcone, Lorenzo De Paoli, Giuseppe Pietrantuono, Silvia Gentili, Caterina Musolino, Nicola Giuliani, Annalisa Bernardini, Concetta Conticello, Stefano Pulini, Giovannino Ciccone, Vladimír Maisnar, Marina Ruggeri, Renato Zambello, Tommasina Guglielmelli, Antonio Ledda, Anna Marina Liberati, Vittorio Montefusco, Roman Hajek, Mario Boccadoro, Antonio Palumbo
Journal: Blood
Blood (2016) 127 (9): 1102–1108.
https://doi.org/10.1182/blood-2015-08-662627
Published: 2016
Includes: Supplemental data
Journal Articles

Minimal Residual Disease Detection By Multiparametric Flow Cytometry in Newly Diagnosed Multiple Myeloma Patients: A Preliminary Analysis of the EMN02/HO95 MM Study

Stefania Oliva, Manuela Gambella, Milena Gilestro, Francesca Gay, Alessandra Larocca, Anna Marina Liberati, Francesca Bonello, Giulia Benevolo, Giovannino Ciccone, Tommaso Caravita, Vittorio Emanuele Muccio, Simona Caltagirone, Stefano Spada, Barbara Gamberi, Simone Ferrero, Marina Ruggeri, Giuseppe Rossi, Elona Saraci, Massimo Offidani, Maria Teresa Petrucci, Mario Boccadoro, MD, Pieter Sonneveld, MD PhD, Antonio Palumbo, Paola Omedè
Journal: Blood
Blood (2015) 126 (23): 1760.
https://doi.org/10.1182/blood.V126.23.1760.1760
Published: 2015
Journal Articles

The Hypoxia-Inducible Factor-1alpha Is Constitutively Upregulated in TP53 Disrupted CLL Cells: A Potential Target to Overcome Fludarabine Resistance

Valentina Griggio, Ms, Candida Vitale, MD, Chiara Riganti, MD, Joanna Kopecka, PhD, Michele Dal Bo, Davide Rossi, MD PhD, Gabriele Pozzato, MD, Luca Laurenti, MD, Francesco Zallio, MD, Monia Marchetti, MD PhD, Marina Ruggeri, Paola Omedè, Giovanni Del Poeta, Pr, MD, Valter Gattei, MD, Gianluca Gaidano, MD PhD, Mario Boccadoro, MD, Massimo Massaia, MD, Marta Coscia, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2925.
https://doi.org/10.1182/blood.V126.23.2925.2925
Published: 2015
Journal Articles

Highly Sensitive Droplet Digital PCR for MYD88 L265P Mutation Detection and Minimal Residual Disease Monitoring in Waldenström Macroglobulinemia

Daniela Drandi, Elisa Genuardi, Paola Ghione, Daniele Grimaldi, Barbara Mantoan, Marina Ruggeri, Daniela Barbero, Luigia Monitillo, Marika Vasta, Eleonora Marzanati, Giulia Verardo, Paola Omedè, Federica Cavallo, Mario Boccadoro, MD, Marco Ladetto, Simone Ferrero
Journal: Blood
Blood (2015) 126 (23): 2645.
https://doi.org/10.1182/blood.V126.23.2645.2645
Published: 2015
Journal Articles

The Combination of Frailty and ISS Scores Identifies a Simple Prognostic Index for Overall Survival in Elderly Patients Treated with Novel Agents-Based Induction Therapy

Alessandra Larocca, MD, Sara Bringhen, MD, Roman Hajek, Maria Teresa Petrucci, MD, Massimo Offidani, MD, Roberto Mina, MD, Vittorio Montefusco, MD, Gabriele Aitoro, MD, Claudia Cellini, MD, Enrico Maria Pogliani, MD, Lorenzo De Paoli, Marina Ruggeri, Laura Maracci, MD, Oreste Villani, MD, Chiara Nozzoli, MD, Alessia La Fauci, MD, Marta Chisini, MD, Francesca Gay, MD, Roberto Marasca, MD, Stelvio Ballanti, MD, Nicola Giuliani, MD PhD, Pellegrino Musto, MD, Mario Boccadoro, MD, Pieter Sonneveld, MDPhD, Antonio Palumbo, MD
Journal: Blood
Blood (2014) 124 (21): 4740.
https://doi.org/10.1182/blood.V124.21.4740.4740
Published: 2014
Journal Articles

Identification of Novel Tumor-Associated Antigens in Chronic Lymphocytic Leukemia (CLL) by Serological Proteome Analysis (SERPA)

Marta Coscia, MD, PhD, Valentina Griggio, Michela Capello, PhD, Candida Vitale, MD, Federica Linty, PhD, Paola Cappello, PhD, Giorgia Mandili, PhD, Barbara Castella, PhD, Myriam Foglietta, MD, Micol Rigoni, PhD, Patrizia Sciancalepore, MD, Marta Robino, Marina Ruggeri, PhD, Daniela Drandi, PhD, Paola Omedè, PhD, Marco Ladetto, MD, Francesco Novelli, MD, Mario Boccadoro, MD, Massimo Massaia, MD
Journal: Blood
Blood (2012) 120 (21): 3878.
https://doi.org/10.1182/blood.V120.21.3878.3878
Published: 2012
Journal Articles

Progressive Telomere Shortening Is Part of the Natural History of Chronic Lymphocytic Leukemia (CLL) and Impacts Clinical Outcome

Elisa Bernocco, MD, Davide Rossi, Elisa Genuardi, PhD, Chiara Lobetti-Bodoni, MD, Roberto Passera, PhD, Daniela Drandi, PhD, Marta Coscia, MD, PhD, Marina Ruggeri, PhD, Marco Fangazio, PhD, Paola Ghione, Daniela Barbero, PhD, Barbara Mantoan, PhD, Sara Barbiero, Manuela Zanni, MD, Valter Gattei, Luciana Bergui, MD, Paola Omedè, PhD, Massimo Massaia, MD, Mario Boccadoro, MD, Gianluca Gaidano, Marco Ladetto, MD
Journal: Blood
Blood (2011) 118 (21): 2845.
https://doi.org/10.1182/blood.V118.21.2845.2845
Published: 2011
Journal Articles

Identification by Serological Proteome Analysis (SERPA) of Tumor-Associated Antigens Eliciting Antibody Responses In Chronic Lymphocytic Leukemia (CLL)

Marta Coscia, MD, PhD, Michela Capello, PhD, Valentina Griggio, PhD, Federica Linty, PhD, Candida Vitale, MD, Silvia Peola, PhD, Barbara Castella, PhD, Micol Rigoni, PhD, Daniela Drandi, PhD, Marina Ruggeri, PhD, Paola Omedè, PhD, Marco Ladetto, MD, Franco Novelli, MD, Mario Boccadoro, MD, Massimo Massaia, MD
Journal: Blood
Blood (2010) 116 (21): 917.
https://doi.org/10.1182/blood.V116.21.917.917
Published: 2010
Journal Articles

Bortezomib-Based Induction Treatments Improve Outcomes of Newly Diagnosed Multiple Myeloma Patients with High-Risk Cytogenetic Abnormalities

Michele Cavo, Sara Bringhen, Carolina Terragna, Paola Omedè, Giulia Marzocchi, Marina Ruggeri, Sandra Durante, Maria Teresa Petrucci, Tommasina Guglielmelli, Giulia Benevolo, Vittorio Montefusco, Franco Narni, Antonietta Falcone, Catello Califano, Anna Baraldi, Silvana Pasini, Piero Galieni, Fortunato Morabito, Mariella Grasso, Daniela Gottardi, Vincenzo Rizzo, Mario Boccadoro, Nicoletta Testoni, Antonio Palumbo
Journal: Blood
Blood (2010) 116 (21): 781.
https://doi.org/10.1182/blood.V116.21.781.781
Published: 2010
Journal Articles

A Phase III Study to Compare Melphalan, Prednisone, Lenalidomide (MPR) Versus Melphalan 200 Mg/m 2 and Autologous Transplantation (MEL200) In Newly Diagnosed Multiple Myeloma Patients

Antonio Palumbo, Federica Cavallo, Izhar Hardan, Giovannino Ciccone, Alessandra Larocca, Maide Cavalli, Jacopo Peccatori, Angelo Michele Carella, Annamaria Brioli, Anna Maria Cafro, Francesca Patriarca, Agostina Siniscalchi, Sara Pezzatti, Claudia Crippa, ittorio Montefusco, V, Anna Levi, Marina Ruggeri, PhD, Tommaso Caravita, Dina Ben Yehuda, Francesco Di Raimondo, Mario Boccadoro
Journal: Blood
Blood (2010) 116 (21): 3573.
https://doi.org/10.1182/blood.V116.21.3573.3573
Published: 2010
Journal Articles

IGHV Unmutated Chronic Lymphocytic Leukemia (CLL) B Cells Are More Susceptible to Spontaneous Apoptosis Than Mutated CLL B Cells and Are Subject to the Anti-Apoptotic Effect of Environmental Signals

Marta Coscia, MD, PhD, Francesca Pantaleoni, PhD, Chiara Riganti, MD, Candida Vitale, MD, Micol Rigoni, PhD, Silvia Peola, PhD, Daniela Drandi, PhD, Barbara Castella, PhD, Marina Ruggeri, PhD, Paola Omedè, MD, Marco Ladetto, MD, Amalia Bosia, MD, Mario Boccadoro, MD, Massimo Massaia, MD
Journal: Blood
Blood (2010) 116 (21): 2431.
https://doi.org/10.1182/blood.V116.21.2431.2431
Published: 2010
Journal Articles

Clinical Outcomes According to Genomic Abnormalities in 566 Newly Diagnosed Multiple Myeloma Patients Treated with Bortezomib-Based Regimens.

Michele Cavo, M.D., Sara Bringhen, M.D., Nicoletta Testoni, B.S., Paola Omedè, B.S., Giulia Marzocchi, B.S., Marina Ruggeri, B.S., Sandra Durante, B.S., Francesco Di Raimondo, M.D., Davide Rossi, M.D., Ausilia Gorgone, M.D., Francesca Patriarca, M.D., Maria Teresa Petrucci, M.D., Silvia Buttignol, M.D., Anna Levi, M.D., Massimo Offidani, M.D., Chiara Nozzoli, M.D., Roberto Ria, M.D., Barbara Olivero, M.D., Monica Galli, M.D., Vittorio Montefusco, M.D., Vincenzo Callea, M.D., Antonietta Falcone, M.D., Antonio De Vivo, M.D., Mario Boccadoro, MD, Carolina Terragna, B.S., Antonio Palumbo, M.D.
Journal: Blood
Blood (2009) 114 (22): 1868.
https://doi.org/10.1182/blood.V114.22.1868.1868
Published: 2009
Journal Articles

Melphalan 200 Mg/m 2 (Mel200) Versus Melphalan 100 Mg/m 2 (Mel100) in Newly Diagnosed Myeloma Patients: A Prospective, Randomized Phase III Study

Mario Boccadoro, MD, Sara Bringhen, MD, Maria Teresa Petrucci, MD, Antonietta Falcone, MD, Anna Marina Liberati, MD, Roberto Ria, MD, Mariella Grasso, MD, Marco Montanaro, MD, Patrizia Pregno, MD, Andrea Nozza, MD, Francesco Pisani, MD, Tommaso Caravita, MD, Clotilde Cangialosi, MD, Elisabetta Calabrese, MD, Alessandra Larocca, MD, Federica Cavallo, MD, Marina Ruggeri, PhD, Pellegrino Musto, MD, Robert Foà, MD, Antonio Palumbo, MD
Journal: Blood
Blood (2008) 112 (11): 3316.
https://doi.org/10.1182/blood.V112.11.3316.3316
Published: 2008